Denali Therapeutics shares owned by EntryPoint Capital
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by EntryPoint Capital
from 13F filings
Historical chart of EntryPoint Capital investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by EntryPoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $349k | 24k | 14.52 |